Alterity Therapeutics Limited
Imidazo [1,5-a]pyridine compounds and their use

Last updated:

Abstract:

The present invention provides compounds that modulate biological metals and to pharmaceutical compositions containing such compounds. The invention particularly relates to imidazo[1,5-a]pyridine compounds of formula (I) that modulate iron and are useful for the treatment of diseases, particularly neurological diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), Alzheimer-type dementia, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and multiple system atrophy (MSA). The compounds of formula (I) being ##STR00001## where variables are defined herein.

Status:
Grant
Type:

Utility

Filling date:

13 Mar 2020

Issue date:

9 Mar 2021